1. Ferlay, J., Soerjomataram, I., Dikshit, R., et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 2015, vol. 136, no. 5, pp. E359–E386. https://doi.org/10.1002/ijc.29210
2. Aran, V., Victorino, A.P., Thuler, L.C., and Ferreira, C.G., Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality, Clin. Colorectal Cancer, 2016, vol. 15, no. 3, pp. 195—203. https://doi.org/10.1016/j.clcc.2016.02.008
3. Grant, D.M., Goodfellow, G.H., Sugamori, K.S., and Durette, K., Pharmacogenetics of the human arylamine N-acetyltransferases, Pharmacology, 2000, vol. 61, no. 3, pp. 204–211. https://doi.org/10.1159/000028402
4. Probst-Hensch, N.M., Haile, R.W., Ingles, S.A., et al., Acetylation polymorphism and prevalence of colorectal adenomas, Cancer Res., 1995, vol. 55, no. 10, pp. 2017–2020.
5. Osian, G., Procopciuc, L., and Vlad, L., NAT2 gene polymorphism and sporadic colorectal cancer: prevalence, tumor stage and prognosis: a preliminary study in 70 patients, J. Gastrointest. Liver Dis., 2006, vol. 15, no. 4, pp. 347–353.